New drug application

From DISI
Revision as of 20:31, 8 October 2012 by Therese (talk | contribs) (2 revisions)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

A new drug application (NDA) is an application submitted by the manufacturer of a drug to the FDA - after clinical trials have been completed - for a license to market the drug for a specified indication.